The most common reason for menopause is the natural decline in a female's reproductive hormones. However, menopause can also result from the following situations:
Oophorectomy: This surgery, which removes a woman's ovaries, causes immediate menopause. Symptoms and signs of menopause in this situation can be severe, as the hormonal changes happen abruptly.
Chemotherapy: Cancer treatments like chemotherapy can induce menopause quickly, causing symptoms to appear shortly after or even during treatment.
Ovarian Insufficiency: Also called premature ovarian failure, this condition is essentially premature menopause. It happens when a woman's ovaries quit functioning before the age of 40 and can stem from genetic factors and disease. Only 1% of women suffer from premature menopause, but HRT can help protect the heart, brain, and bones.
If you're a woman going through menopause and find that you have become increasingly depressed, you're not alone. It's estimated that 15% of women experience depression to some degree while going through menopause. What many women don't know is that depression can start during perimenopause, or the years leading up to menopause.
Depression can be hard to diagnose, especially during perimenopause and menopause. However, if you notice the following signs, it might be time to speak with a physician:
Remember, if you're experiencing depression, you're not weak or broken - you're going through a very regular emotional experience. The good news is that with proper treatment from your doctor, depression isn't a death sentence. And with HRT and anti-aging treatment for women, depression could be the catalyst you need to enjoy a new lease on life.
Hot flashes - they're one of the most well-known symptoms of menopause. Hot flashes are intense, sudden feelings of heat across a woman's upper body. Some last second, while others last minutes, making them incredibly inconvenient and uncomfortable for most women.
Symptoms of hot flashes include:
Typically, hot flashes are caused by a lack of estrogen. Low estrogen levels negatively affect a woman's hypothalamus, the part of the brain that controls body temperature and appetite. Low estrogen levels cause the hypothalamus to incorrectly assume the body is too hot, dilating blood vessels to increase blood flow. Luckily, most women don't have to settle for the uncomfortable feelings that hot flashes cause. HRT treatments for women often stabilize hormones, lessening the effects of hot flashes and menopause in general.
Mood swings are common occurrences for most people - quick shifts from happy to angry and back again, triggered by a specific event. And while many people experience mood swings, they are particularly common for women going through menopause. That's because, during menopause, the female's hormones are often imbalanced. Hormone imbalances and mood swings go hand-in-hand, resulting in frequent mood changes and even symptoms like insomnia.
The rate of production of estrogen, a hormone that fluctuates during menopause, largely determines the rate of production the hormone serotonin, which regulates mood, causing mood swings.
Luckily, HRT and anti-aging treatments in Franklin Lakes, NJ for women work wonders for mood swings by regulating hormone levels like estrogen. With normal hormone levels, women around the world are now learning that they don't have to settle for mood swings during menopause.
Staying fit and healthy is hard for anyone living in modern America. However, for women with hormone imbalances during perimenopause or menopause, weight gain is even more serious. Luckily, HRT treatments for women coupled with a physician-led diet can help keep weight in check. But which hormones need to be regulated?
Lowered sexual desire - three words most men and women hate to hear. Unfortunately, for many women in perimenopausal and menopausal states, it's just a reality of life. Thankfully, today, HRT and anti-aging treatments Franklin Lakes, NJ can help women maintain a normal, healthy sex drive. But what causes low libido in women, especially as they get older?
The hormones responsible for low libido in women are progesterone, estrogen, and testosterone.
Progesterone production decreases during perimenopause, causing low sex drive in women. Lower progesterone production can also cause chronic fatigue, weight gain, and other symptoms. On the other hand, lower estrogen levels during menopause lead to vaginal dryness and even vaginal atrophy or loss of muscle tension.
Lastly, testosterone plays a role in lowered libido. And while testosterone is often grouped as a male hormone, it contributes to important health and regulatory functionality in women. A woman's testosterone serves to heighten sexual responses and enhances orgasms. When the ovaries are unable to produce sufficient levels of testosterone, it often results in a lowered sex drive.
Often uncomfortable and even painful, vaginal dryness is a serious problem for sexually active women. However, like hair loss in males, vaginal dryness is very common - almost 50% of women suffer from it during menopause.
Getting older is just a part of life, but that doesn't mean you have to settle for the side effects. HRT and anti-aging treatments for women correct vaginal dryness by re-balancing estrogen, progesterone, and testosterone. When supplemented with diet and healthy living, your vagina's secretions are normalized, causing discomfort to recede.
Uterine fibroids - they're perhaps the least-known symptom of menopause and hormone imbalances in women. That's because these growths on the uterus are often symptom-free. Unfortunately, these growths can be cancerous, presenting a danger for women as they age.
Many women will have fibroids at some point. Because they're symptomless, they're usually found during routine doctor exams. Some women only get one or two, while others may have large clusters of fibroids. Because fibroids are usually caused by hormone imbalances, hysterectomies have been used as a solution, forcing women into early menopause.
Advances in HRT and anti-aging medicine for women give females a safer, non-surgical option without having to experience menopause early. At Global Life Rejuvenation, our expert physicians will implement a customized HRT program to stabilize your hormones and reduce the risk of cancerous fibroid growth.
Endometriosis symptoms are much like the effects of PMS, and include pelvic pain, fatigue, cramping, and bloating. While doctors aren't entirely sure what causes this painful, uncomfortable condition, most agree that hormones - particularly xenoestrogens - play a factor.
Endometriosis symptoms are much like the effects of PMS and include pelvic pain, fatigue, cramping, and bloating. While doctors aren't entirely sure what causes this painful, uncomfortable condition, most agree that hormones - particularly xenoestrogens - play a factor.
Xenoestrogen is a hormone that is very similar to estrogen. Too much xenoestrogen is thought to stimulate endometrial tissue growth. HRT for women helps balance these hormones and, when used with a custom nutrition program, can provide relief for women across the U.S.
Sermorelin is a synthetic hormone peptide, like GHRH, which triggers the release of growth hormones. When used under the care of a qualified physician, Sermorelin can help you lose weight, increase your energy levels, and help you feel much younger.
Human growth hormone (HGH) therapy has been used for years to treat hormone deficiencies. Unlike HGH, which directly replaces declining human growth hormone levels, Sermorelin addresses the underlying cause of decreased HGH, stimulating the pituitary gland naturally. This approach keeps the mechanisms of growth hormone production active.
Ipamorelin helps to release growth hormones in a person's body by mimicking a peptide called ghrelin. Ghrelin is one of three hormones which work together to regulate the growth hormone levels released by the pituitary gland. Because Ipamorelin stimulates the body to produce growth hormone, your body won't stop its natural growth hormone production, which occurs with synthetic HGH.
Ipamorelin causes growth hormone secretion that resembles natural release patterns rather than being constantly elevated from HGH. Because ipamorelin stimulates the natural production of growth hormone, our patients can use this treatment long-term with fewer health risks.
One of the biggest benefits of Ipamorelin is that it provides significant short and long-term benefits in age management therapies. Ipamorelin can boost a patient's overall health, wellbeing, and outlook on life.
When growth hormone is produced by the pituitary gland using Ipamorelin, clients report amazing benefits. Some of those benefits include:
Whether you are considering our HRT and anti-aging treatments for women in Franklin Lakes, NJ, we are here to help. The first step to reclaiming your life begins by contacting Global Life Rejuvenation. Our friendly, knowledgeable HRT experts can help answer your questions and walk you through our procedures. From there, we'll figure out which treatments are right for you. Before you know it, you'll be well on your way to looking and feeling better than you have in years!973-587-8638
A group of Franklin Avenue Middle School students won a national career exploration competition with their proposal to help save the bees.FRANKLIN LAKES, NJ — Every time one of her seventh-grade students asks Alyssa McAloney why she wanted to teach, the Franklin Avenue Middle School teacher said, she tells them she wanted to share her love of science with others, and show real-life examples in which science is used.In continuing with those principles, McAloney entered her students, who were in the school's gifted and ta...
FRANKLIN LAKES, NJ — Every time one of her seventh-grade students asks Alyssa McAloney why she wanted to teach, the Franklin Avenue Middle School teacher said, she tells them she wanted to share her love of science with others, and show real-life examples in which science is used.
In continuing with those principles, McAloney entered her students, who were in the school's gifted and talented program, into a national competition designed to encourage career exploration, and though they encountered difficulties, they beat over 500 teams to win with their proposed solution to help save the bees.
"Finding out the students won was pretty incredible," McAloney said. "I was thrilled, and they were thrilled. Their faces just lit up; they couldn't believe it."
The group of four students, known as Team Passion Project, with the help of their teacher McAloney, was awarded $10,000 for the school and $1,500 to split among them, after winning the American Student Assistance "Solve Together" competition earlier this summer.
All four of the students were in McAloney's science class as well, where the problem of disappearing bees was discussed, and that, she said, motivated the students to raise awareness about saving the bee population. Around the same time, McAloney found out about the contest and thought it would serve as a good career exploration activity for the students.
For their winning project proposal, the students approached the problem of honeybee decline from the perspective of a professional bee transporter, and they looked specifically at how transportation often puts stress on the bees.
After researching the issue, the students interviewed experts, including a current bee transporter and a Cornell University agricultural professor, and created a prototype out of cardboard of a transport truck that would ensure proper storage at the ideal temperature.
For two months, the students worked to finalize the presentation to show the judges of the contest, which had submissions across 48 states.
"They deserved (the win). They worked hard, and it was a tough challenge," McAloney said, adding that she hopes one of the students will aspire to, one day, keep bees of their own now, or even see it as a possible career path.
Companies combine key capabilities to advance flow cytometry as an essential companion diagnostic modality for cancer and other diseasesFRANKLIN LAKES, N.J., Aug. 9, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology co...
Companies combine key capabilities to advance flow cytometry as an essential companion diagnostic modality for cancer and other diseases
FRANKLIN LAKES, N.J., Aug. 9, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration agreement with Labcorp (NYSE: LH), a leading global life sciences company, creating a framework to develop, manufacture, market and commercialize flow cytometry-based companion diagnostics (CDx) intended to match patients with life-changing treatments for cancer and other diseases.
The agreement creates a framework for BD and Labcorp Drug Development to collaborate on flow cytometry-based CDx opportunities with pharmaceutical partners. The two companies bring together capabilities that comprise an end-to-end solution for CDx development for the pharmaceutical industry. Their joint offering ranges from exploratory panel development to U.S. Food and Drug Administration (FDA) approval of diagnostic and IVD kit manufacturing and distribution.
"Flow cytometry is a trusted and powerful tool for analyzing cells to better understand disease, and it has tremendous untapped potential as a companion diagnostic in oncology and other therapeutic areas," said Dr. Bill Hanlon, chief scientific officer of Labcorp Drug Development. "This strategic collaboration with BD, a pioneer and global leader in flow cytometry, is an exciting step toward increasing adoption and ultimately bringing innovative new companion diagnostics to market to help identify patients who could benefit most from appropriate treatments."
Selecting the optimal first-line therapy for patients with cancer by using companion diagnostics can be critical to ensuring the best outcomes and time and cost savings. Today's companion diagnostic tests commonly involve technologies such as immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), next-generation sequencing (NGS) and imaging. Flow cytometry is an emerging technology in the field.
"In the companion diagnostic landscape, there is a clear and urgent need for high sensitivity and multiplexing capabilities, and that is where flow cytometry can help," said Puneet Sarin, president of BD Biosciences. "BD and our dedicated CDx team are uniquely positioned to advance flow cytometry as a companion diagnostic tool, and we are pleased to join forces with Labcorp, a trusted global leader in diagnostic testing and drug development, to pursue opportunities with the pharmaceutical industry to develop new companion diagnostics that can potentially improve patient outcomes and drive us forward in advancing the world of health."
About BDBD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
VP, Public Relations
SVP, Head of Investor Relations
SOURCE BD (Becton, Dickinson and Company)
Ten Hamilton College women's tennis players have earned 2022 Division III Women's Scholar-Athlete honors from the Intercollegiate Tennis Association (ITA).ITA 2022 Women's Academic Awards release | Scholar-Athlete list | ...
Ten Hamilton College women's tennis players have earned 2022 Division III Women's Scholar-Athlete honors from the Intercollegiate Tennis Association (ITA).
The Continentals were also named an ITA All-Academic Team for having a team grade point average of 3.2 or better. All varsity letter winners were factored into the cumulative team GPA for the 2021-22 academic year. The women -- led by Head Coach Mandy Gamble -- picked up an ITA all-academic team award for the eighth straight year. Gamble just finished her first season with the team.
Sarah Bargamian '22 and Eleanor Struthers '22 made the list for the fourth time after they posted a grade point average of 3.5 or better during the past academic year. Hannah Apsey '25 was No. 21 in the final 2022 ITA Northeast Region Singles Rankings, and Apsey and Kat Roberts '22 were No. 15 in the final regional doubles rankings. The entire Hamilton list can be found below.
Hannah Apsey '25 (Allendale, N.J./Northern Highlands Regional HS) Sarah Bargamian '22 (Wayland, Mass./The Rivers School) Shannon Cicero '25 (Franklin Lakes, N.J./Ramapo HS) Grace Fuss '24 (Santa Barbara, Calif./Cate School) Lorelei Glidden '24 (Tempe, Ariz./Xavier College Preparatory) Lauren Holtzman '23 (Berkeley Heights, N.J./Newark Academy) Stephanie Pratt '25 (Beverly, Mass./Manchester Essex Regional HS) Kat Roberts '22 (Oak Bluffs, Mass./Martha's Vineyard Regional HS) Kate Solowey '25 (Sudbury, Mass./Lincoln-Sudbury Regional HS) Eleanor Struthers '22 (West Hartford, Conn./Loomis Chaffee School)
Funding to Four Community Health Centers Advances Medication Management Programs for Vulnerable Patients Managing Chronic DiseaseFRANKLIN LAKES, N.J., Aug. 8, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company, along with Direct Relief and the National Association of Community Health Centers (NACHC), today announced they have awarded four community health centers with a total of $1.08 million to implement programs to support chronic disease management to underserved communities....
Funding to Four Community Health Centers Advances Medication Management Programs for Vulnerable Patients Managing Chronic Disease
FRANKLIN LAKES, N.J., Aug. 8, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company, along with Direct Relief and the National Association of Community Health Centers (NACHC), today announced they have awarded four community health centers with a total of $1.08 million to implement programs to support chronic disease management to underserved communities.
The BD Helping Build Healthy Communities™ Innovations in Care award recognizes U.S. community health centers for excellence in helping vulnerable patients manage their complex chronic diseases and improve their overall health. This year's awardees will receive a grant for $270,000 each to build upon the demonstrated impact their novel care approaches have on at-risk populations. All four community health centers also received the Innovations in Care award in 2021.
The supplemental funding will enable the health centers to continue enhancing impact through holistic, culturally sensitive, team-based care and by providing pharmacist-led patient education and counseling. The funding will also be used to help remove barriers to care by addressing Social Determinants of Health (SDOH) — including where people are born, live, learn, work, play, worship and their age, all of which affect a wide range of health and quality-of-life outcomes and risks.
"Racial and ethnic minorities in the United States are more likely to experience worse health outcomes for complex chronic conditions, yet less likely to receive preventive health services," said Tom Polen, chairman, CEO and president of BD. "We are directly addressing these health inequities by investing in community health centers that help ensure underserved patients receive quality care. These centers are located in high-need areas, available to all regardless of their ability to pay, and deliver culturally relevant care to meet the specific needs and priorities of their communities."
The following Innovations in Care 2022 award winners are:
Thomas Tighe, president and CEO of Direct Relief said, "This effort is an extraordinary example of leadership by BD to award and elevate initiatives from community health centers that improve the health and lives of people with chronic health conditions. Direct Relief is deeply grateful to BD and to NACHC for their collaboration and support."
"Health centers are more than healers. Health centers are problem-solvers who reach beyond the walls of the conventional health care delivery system to address the social drivers of health, such as stable housing, food insecurity, mental health and so much more," said Rachel A. Gonzales-Hanson, interim president and CEO of NACHC. "Private funding partnerships made possible by BD and Direct Relief are essential to support innovative approaches that health centers bring to foster wellness and health equity in underserved communities."
The BD Helping Build Healthy Communities initiative, which is funded by BD and the BD Foundation, and implemented jointly by Direct Relief and NACHC, has provided 52 awards to community health centers in 20 states since 2013, with a total commitment of $22.6 million in cash and product donations. Visit news.bd.com/esg for more information on the company's environmental, social and governance commitments and progress.
For more information about the 2022 winners of BD Helping Build Healthy Communities Innovations in Care award, visit www.directrelief.org/bdhbhc.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
About Direct Relief
A humanitarian organization committed to improving the health and lives of people affected by poverty and emergencies, Direct Relief delivers lifesaving medical resources throughout the U.S. and world to communities in need – without regard to politics, religion, or ability to pay. For more information, visit www.DirectRelief.org.
About National Association of Community Health Centers
Established in 1971, the National Association of Community Health Centers (NACHC) serves as the leading national voice for America's Health Centers and as an advocate for health care access for the medically underserved and uninsured. For more information, visit www.nachc.org.
SVP, Head of Investor Relations
SOURCE BD (Becton, Dickinson and Company)
HOBOKEN — A low-income Hudson County man could lose the place he calls home as the result of a lengthy legal dispute with his landlord.Jeff Trupiano has lived in his Hoboken apartment-turned-condo for over three decades. He moved into the rent-controlled unit at 703 Park Ave. in 1991 under a former owner.For the past five years, Trupiano has been locked in a legal battle with his landlord over a significant rent increase. Court records show that the landlord tried jacking the monthly rent by nearly $3,000 and is attemptin...
HOBOKEN — A low-income Hudson County man could lose the place he calls home as the result of a lengthy legal dispute with his landlord.
Jeff Trupiano has lived in his Hoboken apartment-turned-condo for over three decades. He moved into the rent-controlled unit at 703 Park Ave. in 1991 under a former owner.
For the past five years, Trupiano has been locked in a legal battle with his landlord over a significant rent increase. Court records show that the landlord tried jacking the monthly rent by nearly $3,000 and is attempting to get retroactive rent from Trupiano.
A few years after Trupiano moved in, the apartment building was bought by Amaconn Realty, Inc. Then in 2001, the owner, who is Trupiano's landlord, turned the apartments into condominiums.
Sales records on Zillow.com show that one two-bedroom condo at the building was sold in April for $449,000.
Trupiano, who is in his 60s and makes less than $30,000 a year working at a local health food store, pays $783 in rent each month. His attorney, Dana Wefer, told New Jersey 101.5 that as a low-income renter, he has been protected from eviction for more than 20 years because of the Tenant Protection Act.
But in 2017, Trupiano's landlord issued a hardship increase based on an appraisal of his unit. Wefer said that the appraisal was "hypothetical" and based on how much the unit could bring in if it were completely renovated.
According to a briefing provided by Wefer, the landlord knew that the building had a protected tenant and chose to proceed with the conversion anyway. It also notes that Trupiano continues to pay his rent on time despite the unit having been neglected for years.
"The property has been fundamentally transformed from one that was a prudent and sound investment to a single ill-maintained rent-controlled condominium unit, encumbered with a protected tenant who cannot be evicted for twenty-six years."
A GoFundMe is raising money for Trupiano's court costs and increasing rent. Created by the Hoboken Fair Housing Association, the fundraiser claims that an unfavorable decision could gut the Tenant Protection Act.
While Wefer is handling the case pro bono, there are high costs for appealing court decisions including the requirement to pay for thousands of pages of transcripts. Wefer said that they will likely need to appeal as a judge recently gave an oral decision stating that Trupiano's rent should increase based on the property's equity.
Wefer added that it's not hyperbole to say that the Tenant Protection Act is at risk. The attorney said she would not be surprised to see Trupiano's case go up to the New Jersey Supreme Court.
Previous rulings from the state's highest court, such as Mayes v. Jackson Township Rent Leveling Board (1986), have upheld rent control ordinances and a landlord's right to "realize a just and reasonable return on the property."
An attorney for the landlord did not respond to a request for comment.